Month: April 2021

Company commences workover on existing producing wells on the leasehold. Overland Park, KS, April 12, 2021 (GLOBE NEWSWIRE) — Infinity Energy Resources, Inc. (Pink Sheets: IFNY) (“Infinity” or the “Company”), an independent oil and gas exploration and development company, announced that it has closed the purchase of 100% of the working interest in a leasehold containing current oil and gas production and mineral rights in a proven basin in the Central Kansas Uplift geological formation covering approximately 11,000 acres (the “Properties”). The Company purchased the Properties from Core Energy, LLC, a closely held company (“Core”) pursuant to an option it had previously acquired. The option provided the Company the right to acquire the Properties for $900,000 which was paid at closing...

SOUTH SAN FRANCISCO, Calif. and STAMFORD, Conn., April 12, 2021 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer, and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that the first patient has been dosed in a Phase 1 trial evaluating ALLO-715, Allogene’s investigational anti-B-cell maturation antigen (BCMA) AlloCAR T therapy, in combination with nirogacestat, SpringWorks’ investigational gamma secretase inhibitor (GSI), in patients with relapsed or refractory multiple myeloma. “We are pleased to have initiated this portion...

– Built Internal GMP Commercial Process and Manufacturing Platform and Scaled HEK293 Suspension System to 2,000L Under His Leadership – BEDFORD, Mass., April 12, 2021 (GLOBE NEWSWIRE) — Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Tim Kelly has been promoted to Chief Operating Officer, effective immediately. Previously, Mr. Kelly held the role of Chief Technical Operations Officer and led the construction of the Company’s internal 25,000-square-foot GMP manufacturing facility, which was completed in 12 months from design to operation. As one of the first companies to scale to a 2,000-liter bioreactor with a HEK293 serum-free suspension system, Homology’s commercial scale process and platform gives the Company the ability to produce large scale volumes to support its gene...

Initial safety data expected from CAReS Study before end of 2021 Targeting multi-billion market with no approved therapies for cancer-related anorexia LA JOLLA, Calif., April 12, 2021 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid-signaling signaling pathways, including the endocannabinoid system, today announced that the first patient has been dosed in the Company’s Phase 1/2 Cancer Appetite Recovery Study (CAReS) of ART27.13 in Edinburgh, Scotland, UK. ART27.13 is a peripherally selective G-Protein Coupled Receptor (GPCR) full agonist that is being developed as a much-needed therapy for cancer patients suffering from anorexia and weight loss, which affects over 60% of later-stage cancer patients, often impacts quality...

TORONTO, April 12, 2021 (GLOBE NEWSWIRE) — April 12, 2021 – VITALHUB CORP. (TSXV: VHI) (the “Company” or “VitalHub”), is pleased to announce today it has entered into an agreement (the “Agreement”) with Jayex Healthcare Limited (ASX: JHL) (“Jayex”), a leading UK and Australian e-health provider of integrated SaaS healthcare services delivery platforms, to purchase the assets (the “Acquisition”) of Jayex’s on-premise hospital queue management business segment (“Jayex System”). Total consideration to be paid by VitalHub is expected to be £1.3M (the “Purchase Price”). Jayex will receive the Purchase Price as (i) £1.04M in cash and (ii) £0.26M in VitalHub common shares (the “Shares”). The Shares are to be issued at CAD$2.915 per Share, and will result in 150,078 Shares being issued. In addition, for 24 months after closing of the Acquisition,...

PRINCETON, N.J., April 12, 2021 (GLOBE NEWSWIRE) — Advaxis, Inc. (Nasdaq: ADXS) (the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced it has entered into definitive agreements with two healthcare-focused, institutional investors for the purchase of (i) 17,577,400 shares of common stock , (ii) 7,671,937 pre-funded warrants (the “Pre-Funded Warrants”) to purchase 7,671,937 shares of common stock and (iii) registered common share purchase warrants to purchase 11,244,135 shares of common stock. The Company has also agreed to issue to the investors, in a concurrent private placement, unregistered common share purchase warrants to purchase 14,005,202 shares of the Company’s common stock. Each share of common stock and accompanying common share...

HOUSTON, April 12, 2021 (GLOBE NEWSWIRE) — TC Energy Corporation (TSE, NYSE: TRP) (TC Energy or the Company) announced today that it is seeking, through the issuance of a Request for Information (RFI), to identify potential contract and/or investment opportunities in wind energy projects that could generate up to 2,500,000 megawatt hours per year or 620 megawatts of zero-carbon energy to meet the electricity needs for a portion of its pipeline assets along its U.S. corridor. The RFI, issued by Marathon Capital (Marathon) on behalf of the Company, is non-binding and does not commit TC Energy to any further action if the indicative terms received pursuant to the RFI are not satisfactory. Selection process and timingThe RFI is open from April 12 to May 10, 2021 and will be issued to approximately 100 renewable development companies...

Kelowna, BC, April 12, 2021 (GLOBE NEWSWIRE) — GTEC Holdings Ltd. (TSXV:GTEC) (OTCQB: GGTTF) (FRA: 1BUP) (“GTEC”, the “Company” or “GTEC Cannabis Co.”) a multi-licensed producer of handcrafted, high quality cannabis, is pleased to announce that it has repaid its two Senior Secured Promissory Notes (the “Notes”) with NFS Leasing Canada Ltd. (“NFS”) in full. The Notes, which carried an aggregate principal balance of approximately $6 million, were fully repaid on April 9, 2021. The complete elimination of the Company’s debt, including the repayment of the Invictus Promissory Note (as announced on March 1, 2021), will deliver over $1 million in interest savings over the next 12-months. The Company is now free of all debt liabilities, with all security interests removed and the Company’s assets fully unencumbered. Accordingly, the Company...